The impact of religion on medication compliance

Article

Religiously-motivated fasting may affect glaucoma medication compliance rates, according to study results presented at the annual meeting of the American Academy of Ophthalmology (AAO).

Religiously-motivated fasting may affect glaucoma medication compliance rates, according to study results presented at the annual meeting of the American Academy of Ophthalmology (AAO).

Following on from an initial study assessing medication compliance rates in Muslims during the mandatory fasting period of Ramadan, Nishant Kumar, MBBS of University Hospital, Liverpool, UK and colleagues analyzed 350 surveys completed by respondents self-identified as members of the following faiths: Islam, Christianity, Judaism, Hinduism, Buddhism, Jainism and Bahá'í.

Dr Kumar’s initial study in Muslims showed significantly reduced medication compliance rates during Ramadan, as, during this period, Muslims abstain from fluid as well as food. This period of non-compliance was significant enough that an adverse effect on vision was possible. In the new study, the majority of Hindu, Muslim and Jain respondents stated that they would be unlikely to use eye drops during periods of fasting except in the case of severe pain or advanced disease, while the respondents of other religious beliefs stated that they were likely to remain compliant with their medication.

The team concluded that these periods of fasting have a potential impact on medication compliance, and therefore disease progression; it is essential that ophthalmologists are aware of their patients’ religious beliefs in order to formulate appropriate disease management plans.

Recent Videos
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.